Islay Capital Management LLC lifted its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 591.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,394 shares of the company's stock after acquiring an additional 5,469 shares during the period. Islay Capital Management LLC's holdings in Cardinal Health were worth $756,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also modified their holdings of CAH. State Street Corp increased its stake in shares of Cardinal Health by 4.6% in the 3rd quarter. State Street Corp now owns 14,177,641 shares of the company's stock worth $1,566,913,000 after acquiring an additional 627,253 shares during the last quarter. Geode Capital Management LLC grew its position in Cardinal Health by 1.9% in the 4th quarter. Geode Capital Management LLC now owns 5,859,132 shares of the company's stock valued at $691,145,000 after acquiring an additional 109,273 shares in the last quarter. Amundi lifted its position in shares of Cardinal Health by 5.5% during the fourth quarter. Amundi now owns 2,116,291 shares of the company's stock worth $259,309,000 after purchasing an additional 110,605 shares in the last quarter. Norges Bank purchased a new position in shares of Cardinal Health in the fourth quarter valued at approximately $246,748,000. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of Cardinal Health by 3.0% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,519,011 shares of the company's stock valued at $179,653,000 after purchasing an additional 44,386 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company's stock.
Wall Street Analyst Weigh In
Several equities analysts have commented on CAH shares. Mizuho upped their price objective on Cardinal Health from $142.00 to $150.00 and gave the stock an "outperform" rating in a research report on Monday, March 31st. JPMorgan Chase & Co. increased their price target on Cardinal Health from $142.00 to $145.00 and gave the company a "neutral" rating in a research report on Tuesday, February 4th. Bank of America raised Cardinal Health from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $132.00 to $145.00 in a research report on Monday, January 6th. Citigroup raised their target price on shares of Cardinal Health from $120.00 to $129.00 and gave the company a "neutral" rating in a report on Friday, January 10th. Finally, Jefferies Financial Group upgraded shares of Cardinal Health from a "hold" rating to a "buy" rating and boosted their price target for the stock from $140.00 to $150.00 in a report on Wednesday, February 5th. Four research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $140.14.
Read Our Latest Report on Cardinal Health
Cardinal Health Trading Down 2.5 %
CAH stock traded down $3.31 on Thursday, hitting $127.14. The company's stock had a trading volume of 1,368,451 shares, compared to its average volume of 2,164,991. The stock has a market cap of $30.71 billion, a price-to-earnings ratio of 23.62, a price-to-earnings-growth ratio of 1.49 and a beta of 0.61. The firm has a 50 day moving average of $129.13 and a two-hundred day moving average of $122.10. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $139.50.
Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, equities analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.
Cardinal Health Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a $0.5056 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a yield of 1.59%. Cardinal Health's payout ratio is currently 37.69%.
Cardinal Health Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Stories

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.